Conference
Æ-941, an inhibitor of angiogenesis:: Rationale for a phase III study on Æ-941 in combination with induction chemotherapy/radiotherapy in patients with non small cell lung cancer (NSCLC).
Authors
Evans WK; Latreille J; Batist G; Falardeau P; Champagne P; Dupont É
Volume
5
Pagination
pp. 3774S-3774S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
November 1, 1999
Conference proceedings
CLINICAL CANCER RESEARCH
ISSN
1078-0432